Establishment Labs Holdings Long-Term Investments 2017-2024 | ESTA
Establishment Labs Holdings long-term investments from 2017 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
| Establishment Labs Holdings Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| Establishment Labs Holdings Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.050B | $0.165B |
| Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $91.424B | 11.34 |
| Cencora (COR) | United States | $47.484B | 17.51 |
| DiDi Global (DIDIY) | China | $23.330B | 0.00 |
| Natera (NTRA) | United States | $21.401B | 0.00 |
| ICON (ICLR) | Ireland | $16.136B | 14.37 |
| Viatris (VTRS) | United States | $15.576B | 4.80 |
| Avantor (AVTR) | United States | $13.422B | 20.12 |
| Revvity (RVTY) | United States | $13.376B | 23.24 |
| CochLear (CHEOY) | Australia | $12.844B | 0.00 |
| BioMerieux (BMXMF) | France | $12.666B | 0.00 |
| Solventum (SOLV) | United States | $11.583B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.789B | 27.58 |
| Doximity (DOCS) | United States | $9.620B | 56.63 |
| Charles River Laboratories (CRL) | United States | $9.516B | 18.39 |
| HealthEquity (HQY) | United States | $8.966B | 48.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.758B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.885B | 32.05 |
| Life Times (LTH) | United States | $5.085B | 33.66 |
| Sotera Health (SHC) | United States | $3.855B | 20.62 |
| Organon (OGN) | United States | $3.757B | 3.79 |
| BrightSpring Health Services (BTSG) | United States | $3.247B | 69.07 |
| Surgery Partners (SGRY) | United States | $2.892B | 32.97 |
| PACS (PACS) | United States | $2.606B | 0.00 |
| Concentras Parent (CON) | United States | $2.581B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.375B | 0.00 |
| Premier (PINC) | United States | $2.143B | 11.15 |
| Alignment Healthcare (ALHC) | United States | $2.126B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.952B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.616B | 42.40 |
| Teladoc Health (TDOC) | United States | $1.537B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.255B | 12.28 |
| CareDx (CDNA) | United States | $1.183B | 0.00 |
| Progyny (PGNY) | United States | $1.164B | 23.57 |
| AMN Healthcare Services Inc (AMN) | United States | $0.954B | 6.46 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Embecta (EMBC) | United States | $0.778B | 5.18 |
| SBC Medicals (SBC) | United States | $0.677B | 0.00 |
| Agilon Health (AGL) | United States | $0.655B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.647B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.536B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.425B | 0.00 |
| DocGo (DCGO) | United States | $0.410B | 15.46 |
| Enhabit (EHAB) | United States | $0.366B | 31.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.326B | 0.00 |
| LifeMD (LFMD) | United States | $0.241B | 0.00 |
| ModivCare (MODV) | United States | $0.223B | 12.09 |
| Sera Prognostics (SERA) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Biodesix (BDSX) | United States | $0.180B | 0.00 |
| Nutex Health (NUTX) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.100B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.25 |
| MultiPlan (MPLN) | United States | $0.084B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.043B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.08 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.020B | 0.00 |
| Oncology Institute (TOI) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |